Why Pfizer Stock Didn't Soar After Its Fantastic Q1 Results

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 14, 2021 at 11:02 AM.

  1. #1 cafead, May 14, 2021 at 11:02 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Pfizer (NYSE:pFE) recently announced very good first-quarter results. Revenue and profits soared. The big drugmaker even raised its full-year guidance. However, its share price barely moved. In this Motley Fool Live video recorded on May 5, Motley Fool contributors Keith Speights and Brian Orelli discuss why Pfizer stock didn't soar after its fantastic Q1 results.

    article source
     
    Quote

Reply to Thread